Medtech founders say there’s a lack of investor funding for startups that are past early stage but are still pre-revenue.
Profit after tax of $1.87m comes as international software arm becomes biggest revenue driver.
CEO says investors saw signs of recovery with blockbusters return.
The company’s 2020 results show Covid-19 cost the company $25m.
Guidance estimates Covid-19 impact to increase from $25m to $75m during 2021.
Xero says Covid-19 is the right time for acquisition as small businesses seek capital.
Tech company pays 2.5c per share as it eyes end of big capex spending.
The company hopes to hire out streaming equipment for use in grassroots sport.
JB Rousselot talks investor concerns post-results call.
Fibre connections were up, suggesting fixed wireless alternatives not yet undercutting offering.